Efficacy and Safety of S (+) - Ibuprofen in Osteoarthritis Pain (APS003/2020)
National, Multicentre, Randomized, Double-blind, Double-dummy Phase II Clinical Trial to Evaluate the Efficacy and Safety of S (+) - Ibuprofen for Pain Control in Individuals With Osteoarthritis
Sponsor: Apsen Farmaceutica S.A.
This PHASE2 trial investigates Osteoarthritis and is currently completed. Apsen Farmaceutica S.A. leads this study, which shows 8 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Aug 2023 — Jul 2024 [monthly]
Completed PHASE2
Status: Recruiting → Completed
-
Mar 2023 — Aug 2023 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
May 2022 — Mar 2023 [monthly]
Not Yet Recruiting PHASE2
▶ Show 3 earlier versions
-
Mar 2021 — May 2022 [monthly]
Not Yet Recruiting PHASE2
-
Jan 2021 — Mar 2021 [monthly]
Not Yet Recruiting PHASE2
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Apsen Farmaceutica S.A.
For direct contact, visit the study record on ClinicalTrials.gov .